MedAvail(OTC) MDVL

Market CapN/A

Since IPO (2020)-100%

5 Year-100%

1 Year+0%

1 Month+0%

N/A

MedAvail last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-26

MedAvail stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-08-05
1 month	+0%	USD 0.00	2026-06-23
3 month	+0%	USD 0.00	2026-05-22
Year to date	+0%	USD 0.00	2025-12-24
1 year	+0%	USD 0.00	2025-08-26
3 year	-100%	USD 8.22	2023-08-25
5 year	-100%	USD 154.50	2021-08-27
Since inception	-100%	USD 450.00	2020-11-19

MedAvail Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$23.84M

Net Income (TTM)

-$46.48M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Apr 11, 2024

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Apr 11, 2024

MDVL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MedAvail

MedAvail Holdings, Inc. is a technology-driven provider of retail pharmacy services and solutions in the United States and Canada. The company specializes in self-service pharmacy systems, mobile applications, and kiosk-based solutions, with a focus on enhancing patient access to medications.

Products and Services

MedAvail MedCenter for on-site prescription dispensing
Mobile applications for medication management
Kiosk-based solutions for retail and clinical environments

Growth Outlook

Recent quarterly revenue of $405,000 shows potential for recovery
Cash and cash equivalents of $15 million provide operational flexibility
Current ratio of 4.03 indicates strong short-term financial health

Financial Highlights

Net income for Q2 2023 was -$5.79 million, reflecting ongoing challenges
Operating expenses reached $4.63 million in Q2 2023, impacting profitability
Trailing twelve months (TTM) revenue of $4.05 million indicates a need for growth

MedAvail Holdings, Inc. operates in the healthcare sector, focusing on innovative pharmacy solutions. The MedAvail MedCenter is a key product, allowing for real-time pharmacist consultations during medication dispensing. Despite recent financial challenges, including significant net losses, the company maintains a robust cash position, which may support future growth initiatives. The current ratio suggests that MedAvail is well-positioned to meet its short-term obligations, while the recent revenue figures indicate potential for recovery. Investors may find interest in the company's unique offerings and its strategic focus on enhancing patient access to medications through technology.

AI Generated • Aug 19, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

279

CEO

Mark Doerr

Website

medavail.com

Headquarters

Mississauga, ON L5N 5M4, CA

MDVL Financials

Key Financial Metrics (TTM)

Gross Margin

6.00%

Operating Margin

-107.69%

Net Income Margin

-110.45%

Return on Equity

-238.69%

Return on Capital

-166.39%

Return on Assets

-143.72%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.60M

Operating Income

-$31.70M

EBITDA

-$37.76M

Operating Cash Flow

-$31.54M

Capital Expenditure

-$692.00K

Free Cash Flow

-$32.23M

Cash & ST Invst.

$14.36M

Total Debt

$2.26M

MedAvail Performance Analysis

MedAvail annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 22,129,000	N/A
2022	2022-12-31	USD 43,109,000	94.8%

MedAvail sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2022-09-30	2.5%
Q4	2022-12-31	-1.0%
Q1	2023-03-31	-94.5%
Q2	2023-06-30	-34.7%

MedAvail annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -67.09	N/A
2022	2022-12-31	USD -36.20	-46.0%

MedAvail sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2022-09-30	10.4%
Q4	2022-12-31	8.9%
Q1	2023-03-31	-58.0%
Q2	2023-06-30	70.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2023YOY CHG

Revenue

$405.00K

-96.4%

Gross Profit

$178.00K

-80.6%

Gross Margin

43.95%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

279

N/A

Net Income

-$5.79M

+50.6%

EBITDA

-$4.92M

+54.2%

Quarterly Fundamentals

Name

Q2 2023YOY CHG

Total Cash

$14.36M

-50.8%

Total Debt

$2.26M

-81.7%

Accounts Receivable

$292.00K

-85.9%

Inventory

$10.07M

+79.1%

Long Term Debt

$2.06M

-82.3%

Short Term Debt

$208.00K

-72.0%

Return on Assets

-1.44%

N/A

Return on Invested Capital

-1.71%

N/A

Free Cash Flow

-$4.47M

+66.4%

Operating Cash Flow

-$4.38M

+64.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ARAVAravive, Inc.

ARAVAravive, Inc.$0.04-13.39%

QTTBQ32 Bio Inc.

QTTBQ32 Bio Inc.$14.36-3.43%

IDRAIdera Pharmaceuticals, Inc.

IDRAIdera Pharmaceuticals, Inc.$0.43-23.04%

BPTSBiophytis S.A.

BPTSBiophytis S.A.$8.22-13.47%

PTNPalatin Technologies, Inc.

PTNPalatin Technologies, Inc.$11.54+15.52%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$14.06+0.06%

NVDANvidia

NVDANvidia$217.44-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.33-0.06%

INTCIntel

INTCIntel$88.97-0.01%

ONDSOndas

ONDSOndas$7.04-0.08%

NUNu Holdings

NUNu Holdings$14.46-0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.38-0.02%

Questions About MDVL

What is the current price of MedAvail?

MedAvail is trading at N/A per share.

What is the 52-week range for MedAvail?

Over the past 52 weeks, MedAvail has traded between N/A and N/A.

How much debt does MedAvail have?

As of the most recent reporting period, MedAvail reported total debt of $7.08M.

How much cash does MedAvail have on hand?

MedAvail reported $12.12M in cash and cash equivalents in its most recent financial results.

What is MedAvail’s dividend yield?

MedAvail does not currently have a dividend yield.

MedAvail(OTC) MDVL

MedAvail Financials at a Glance

MDVL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About MedAvail

MDVL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

MedAvail Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MDVL

What is the current price of MedAvail?

What is the 52-week range for MedAvail?

How much debt does MedAvail have?

How much cash does MedAvail have on hand?

What is MedAvail’s dividend yield?

Premium Investing Services